Key result
COPD in heart failure patients was independently associated with increased 1-year all-cause hospitalization in hospitalized (HR 1.16; 95% CI 1.04-1.29) and chronic (HR 1.26; 95% CI 1.13-1.41) cohorts.
Why the study?
Does comorbid COPD worsen 1-year prognosis and impact therapeutic management in hospitalized and chronic heart failure patients?
Observational (n=16,329)
Yes
Does comorbid COPD worsen 1-year prognosis and impact therapeutic management in hospitalized and chronic heart failure patients?
Effect estimate: HR 1.16 (95% CI 1.04-1.29)
COPD frequently coexists in heart failure patients, is associated with lower use of guideline-directed medical therapy like beta-blockers, and independently increases the risk of all-cause and heart failure hospitalizations at 1 year.
No takes yet. Share an insight, caveat, or question.
Comorbid COPD was associated with higher HF hospitalization risk; leaves open whether integrated management or adjusted GDMT improves outcomes.
Canepa et al. (2017) conducted an observational in Heart failure with and without chronic obstructive pulmonary disease (n=16,329). Chronic obstructive pulmonary disease (COPD) vs. Non-COPD was evaluated on All-cause hospitalization at 1 year in hospitalized heart failure patients (HR 1.16, 95% CI 1.04-1.29). COPD in heart failure patients was independently associated with increased 1-year all-cause hospitalization in hospitalized (HR 1.16; 95% CI 1.04-1.29) and chronic (HR 1.26; 95% CI 1.13-1.41) cohorts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: